High-Level Expression of Alkaline Phosphatase by Adeno-Associated Virus Vector Ameliorates Pathological Bone Structure in a Hypophosphatasia Mouse Model

Abstract

Hypophosphatasia (HPP) is a systemic skeletal disease caused by mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNALP). We recently reported that survival of HPP model mice can be prolonged using an adeno-associated virus (AAV) vector expressing bone-targeted TNALP with deca-aspartate at the C terminus (TNALP-D 10); however, abnormal bone structure and hypomineralization remained in the treated mice. Here, to develop a more effective and clinically applicable approach, we assessed whether transfection with TNALP-D 10 expressing virus vector at a higher dose than previously used would ameliorate bone structure defects. We constructed a self-complementary AAV8 vector expressing TNALP driven by the chicken beta-actin (CBA) promoter (scAAV8-CB-TNALP-D 10). The vector was injected into both quadriceps femoris muscles of newborn HPP mice at a dose of 4.5 × 10 12 vector genome (v.g.)/body, resulting in 20 U/mL of serum ALP activity. The 4.5 × 10 12 v.g./body-treated HPP mice grew normally and displayed improved bone structure at the knee joints in X-ray images. Micro-CT analysis showed normal trabecular bone structure and mineralization. The mechanical properties of the femur were also recovered. Histological analysis of the femurs demonstrated that ALP replacement levels were sufficient to promote normal, growth plate cartilage arrangement. These results suggest that AAV vector-mediated high-dose TNALP-D 10 therapy is a promising option for improving the quality of life (QOL) of patients with the infantile form of HPP. Keywords Hypophosphatasia • Adeno-associated virus vector • Enzyme replacement therapy • Alkaline phosphatase • Bone structure Abbreviations AAV Adeno-associated virus ALP Alkaline phosphatase CBA Chicken beta-actin EGFP Enhanced green fluorescence protein Electronic supplementary material The online version of this article (

Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders

“…A further study on the effects of scAAV8-MCK-TNALP-D 10 showed a high doses of 4.5 x 10 12 vg/body injected into the bilateral quadriceps in newborn AKP2−/− mice could increase ALP activity to 20 U/ml in blood and improved the mineralization and bone structure analyzed by micro-CT and radiological analysis. In addition, the histological analysis in growth plate showed normal growth and well-organized cartilage arrangement of AKP2−/− mice treated with 4.5 x 10 12 vg/body [84].…”

Blackcurrant extract promotes the differentiation of MC3T3-E1 pre-osteoblasts

“…OVX rats were used as menopausal models to evaluate the promotion of osteogenic differentiation of femoral tissue. Alkaline phosphatase staining has been shown to be strong in the region surrounding the epiphysis because active osteoblast differentiation occurs there [44]. The femurs of sham rats, OVX rats without BCE treatment (control), and OVX rats treated with 3% BCE were stained for alkaline phosphatase.…”

A new mouse model of Ehlers-Danlos syndrome generated using CRISPR/Cas9-mediated genomic editing

“…Whole spine lateral, forelimb and hindlimb radiographs were recorded on a µFX-1000 film (Fujifilm). Imaging conditions were as follows: tube voltage, 25 kV; tube current, 100 µA; exposure time, 30 s ( Nakamura-Takahashi et al, 2020 ). The forelimbs, forefoot fingers and whole spine lateral at 1 year of age were X-ray irradiated and imaged with a Typhoon FLA-7000 scanner (GE Healthcare).…”